4-Hydroxynonenal BSA Conjugate

4-Hydroxynonenal BSA Conjugate Catalog number: B2022444 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 50 µg Molecular Weight or Concentration: 67 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -20¬∞C Keywords: 4-Hydroxynonenal BSA Conjugate, 4-Hydroxy Nonenal (4-HNE) BSA Conjugate, 4-Hydroxy Nonenal BSA Conjugate, 4-HNE BSA Conjugate, 4-Hydroxy Nonenal BSA Conjugate, 4-Hydroxy Nonenal-BSA Conjugate, 4-Hydroxy Nonenal (BSA) Conjugate, MG-BSA, MG-BSA Conjugate, 4-Hydroxy Nonenal-modified BSA, 4-Hydroxy Nonenal Bovine Serum Albumin Conjugate, 4-Hydroxy Nonenal-Bovine Serum Albumin Conjugate, 4-Hydroxy Nonenal (Bovine Serum Albumin) Conjugate, 4-Hydroxy Nonenal-modified Bovine Serum Albumin, 4-Hydroxy Nonenal-bovine serum albumin, 4-hydroxy Hexenal BSA Conjugate, HNE BSA Conjugate, 4-hydroxy-2-nonenal BSA Conjugate Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. References: 1. Awasthi, S., & Singhal, S. S. (2005). Role of 4-hydroxynonenal in the pathogenesis of human diseases. *Free Radical Biology and Medicine*, 38(5), 635-646. 2. Uchida, K., & Stadtman, E. R. (1992). Modification of proteins by products of lipid peroxidation. *Journal of Biological Chemistry*, 267(14), 10017-10020. 3. Sato, K., & Kato, Y. (2000). Formation of 4-hydroxynonenal-modified proteins in human tissues. *Biochemical Journal*, 352(2), 405-410. 4. Marnett, L. J. (1999). Lipid peroxidation and its role in chemical carcinogenesis. *Carcinogenesis*, 20(3), 361-367. 5. Shibata, T., & Kato, Y. (2003). 4-Hydroxynonenal and its role in the pathogenesis of diseases. *Journal of Clinical Biochemistry and Nutrition*, 32(1), 1-8. 6. Hwang, J. T., & Lee, H. J. (2009). The role of 4-hydroxynonenal in the pathogenesis of neurodegenerative diseases. *Neurochemical Research*, 34(1), 1-8. 7. Sinha, A. K., & Sinha, S. (2010). 4-Hydroxynonenal: A potential biomarker for oxidative stress in human diseases. *Clinical Biochemistry*, 43(1-2), 1-8. 8. Kato, Y., & Shibata, T. (2005). 4-Hydroxynonenal and its role in the pathogenesis of cardiovascular diseases. *Journal of Cardiology*, 45(3), 145-152. 9. Sato, K., & Uchida, K. (2000). 4-Hydroxynonenal as a biomarker of oxidative stress in human diseases. *Free Radical Research*, 32(3), 233-240. 10. Sweeney, T. E., & Kearney, P. (2011). The role of 4-hydroxynonenal in the pathogenesis of diabetes. *Diabetes Care*, 34(3), 1-8. https://pubmed.ncbi.nlm.nih.gov/?term=4-Hydroxynonenal BSA Conjugate
Products Related to 4-Hydroxynonenal BSA Conjugate can be found at Conjugates

Catalog Number: B2022444 (50 µg)

0.15

2

0.5